4-Fluoromethamphetamine
| 4-Fluoromethamphetamine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 459-02-9 |
| PubChem | 12345 |
| DrugBank | |
| ChemSpider | 12345 |
| KEGG | |
4-Fluoromethamphetamine (4-FMA) is a substituted amphetamine and a stimulant drug. It is structurally related to methamphetamine and is part of the fluoroamphetamine class of compounds.
Chemical Properties[edit]
4-Fluoromethamphetamine has the chemical formula C10H13FN. It is a fluorinated derivative of methamphetamine, where a fluorine atom is substituted at the 4-position of the phenyl ring.
Pharmacology[edit]
4-FMA acts as a releasing agent of monoamines, including dopamine, serotonin, and norepinephrine. This action is similar to that of other substituted amphetamines, leading to increased levels of these neurotransmitters in the brain and resulting in stimulant effects.
Effects[edit]
The effects of 4-FMA are similar to those of other stimulants and can include increased alertness, euphoria, and energy. However, the specific effects and their intensity can vary depending on the dose and individual response.
Legal Status[edit]
The legal status of 4-FMA varies by country. In some jurisdictions, it may be controlled under analog laws or specific legislation targeting substituted amphetamines.
Safety and Toxicity[edit]
The safety profile and toxicity of 4-FMA are not well-documented. As with other research chemicals, the potential for adverse effects and long-term health risks is not fully understood. Users should exercise caution and be aware of the potential for neurotoxicity and other harmful effects.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
